| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0006 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0009 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |